Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/40497
Type
ArticleCopyright
Open access
Sustainable Development Goals
03 Saúde e Bem-EstarCollections
- IOC - Artigos de Periódicos [12967]
- MG - IRR - Artigos de Periódicos [4307]
Metadata
Show full item record
CXCR3 CHEMOKINE RECEPTOR GUIDES TRYPANOSOMA CRUZI-SPECIFIC T-CELLS TRIGGERED BY DNA/ADENOVIRUS ASP2 VACCINE TO HEART TISSUE AFTER CHALLENGE
Receptor de Quimiocina
Células T
Vacina ASP2 de DNA / adenovírus
Tecido cardíaco
CXCR3 chemokine receptor guides
T Cells
Vaccine
DNA/adenovirus ASP2
Heart tissue
Author
Affilliation
Universidade Federal de São Paulo. Departamento de Microbiologia, Imunologia e Parasitologia. São Paulo, SP, Brasil.
Universidade Federal de São Paulo. Departamento de Biociências. Santos, SP, Brasil.
Universidade Federal de São Paulo. Departamento de Microbiologia, Imunologia e Parasitologia. São Paulo, SP, Brasil.
Universidade Federal de São Paulo. Departamento de Biofísica. São Paulo, SP, Brasil.
Universidade Federal de São Paulo. Departamento de Biofísica. São Paulo, SP, Brasil.
Universidade Federal de São Paulo. Departamento de Biociências. Santos, SP, Brasil.
Fundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Belo Horizonte, MG, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Biologia das Interações. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Belo Horizonte, MG, Brasil / University of Massachusetts Medical School. Division of Infectious Diseases and Immunology. Worcester, USA.
Universidade Federal de São Paulo. Departamento de Microbiologia, Imunologia e Parasitologia. São Paulo, SP, Brasil / Universidade Federal de São Paulo. Departamento de Biociências. Santos, SP, Brasil.
Universidade Federal de São Paulo. Departamento de Biociências. Santos, SP, Brasil.
Universidade Federal de São Paulo. Departamento de Microbiologia, Imunologia e Parasitologia. São Paulo, SP, Brasil.
Universidade Federal de São Paulo. Departamento de Biofísica. São Paulo, SP, Brasil.
Universidade Federal de São Paulo. Departamento de Biofísica. São Paulo, SP, Brasil.
Universidade Federal de São Paulo. Departamento de Biociências. Santos, SP, Brasil.
Fundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Belo Horizonte, MG, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Biologia das Interações. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Centro de Pesquisas René Rachou. Belo Horizonte, MG, Brasil / University of Massachusetts Medical School. Division of Infectious Diseases and Immunology. Worcester, USA.
Universidade Federal de São Paulo. Departamento de Microbiologia, Imunologia e Parasitologia. São Paulo, SP, Brasil / Universidade Federal de São Paulo. Departamento de Biociências. Santos, SP, Brasil.
Abstract
CD8+ T lymphocytes play an important role in controlling infections by intracellular pathogens. Chemokines and their receptors are crucial for the migration of CD8+ T-lymphocytes, which are the main IFNγ producers and cytotoxic effectors cells. Although the participation of chemokine ligands and receptors has been largely explored in viral infection, much less is known in infection by Trypanosoma cruzi, the causative agent of Chagas disease. After T. cruzi infection, CXCR3 chemokine receptor is highly expressed on the surface of CD8+ T-lymphocytes. Here, we hypothesized that CXCR3 is a key molecule for migration of parasite-specific CD8+ T-cells towards infected tissues, where they may play their effector activities. Using a model of induction of resistance to highly susceptible A/Sn mice using an ASP2-carrying DNA/adenovirus prime-boost strategy, we showed that CXCR3 expression was upregulated on CD8+ T-cells, which selectively migrated towards its ligands CXCL9 and CXCL10. Anti-CXCR3 administration reversed the vaccine-induced resistance to T. cruzi infection in a way associated with hampered cytotoxic activity and increased proapoptotic markers on the H2KK-restricted TEWETGQI-specific CD8+ T-cells. Furthermore, CXCR3 receptor critically guided TEWETGQI-specific effector CD8+ T-cells to the infected heart tissue that express CXCL9 and CXCL10. Overall, our study pointed CXCR3 and its ligands as key molecules to drive T. cruzi-specific effector CD8+ T-cells into the infected heart tissue. The unveiling of the process driving cell migration and colonization of infected tissues by pathogen-specific effector T-cells is a crucial requirement to the development of vaccine strategies.
Keywords in Portuguese
Trypanosoma cruziReceptor de Quimiocina
Células T
Vacina ASP2 de DNA / adenovírus
Tecido cardíaco
Keywords
Trypanosoma cruziCXCR3 chemokine receptor guides
T Cells
Vaccine
DNA/adenovirus ASP2
Heart tissue
Share